Pharmafile Logo
Pharmafocus logo
Advanced Search

MSF challenges Pfizer’s pneumonia vaccine patent in India

March 11, 2016
Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, Prevnar 13, pneumonia vaccine

The charity Médecins Sans Frontières (MSF) has formally opposed Pfizer’s bid to obtain a patent for the pneumonia vaccine PCV13, …

News
grifolslogo

Spanish firm Grifols to spend a total of $360 million on four new plants

March 11, 2016
Manufacturing and Production, Medical Communications grifols, manufacturing, pharma, plasma, production

Grifols (Nasdaq: GRFS) said it will invest a total of $360 million over 2016-2021, to increase the plasma fractionation capacity …

News
facilities_lg06

Dr. Reddy’s, TR-Pharm to collaborate on 3 biosimilars in Turkey

March 11, 2016
Manufacturing and Production, Medical Communications, Sales and Marketing Dr Reddy's Laboratories, TR-Pharm, biosimilar, generics, marketing collaboration

Three biosimilar products by the Indian generics company Dr. Reddy’s will be marketed by TR-Pharm in Turkey, the companies said …

News
arzerra_novartis

Novartis seeks expanded Arzerra use in US

March 11, 2016
Research and Development Arzerra, CLL, FDA, Genmab, Novartis

Novartis has submitted a supplemental Biologics License Application (sBLA) to the US FDA for the use of Arzerra (ofatumumab) in …

News
spark_logo

Spark Therapeutics buys Genable Tech for $6 million in cash and stock deal

March 11, 2016
Business Services, Medical Communications Genable Technologies, Spark Therapeutics, cash & stock, genetic technologies, merger & acquisitions

Spark Therapeutics (Nasdaq: ONCE) said it has acquired Ireland-based Genable Technologies, a privately-held gene therapy firm for $6 million in a cash …

News
shutterstock_38078521

US FDA sets April 25 date to review Sarepta’s DMD drug, shares jump

March 11, 2016
Medical Communications, Research and Development Duchenne Muscular Dystrophy, Eteplirsen, Sarepta Therapeutics, US FDA

Shares in US-based Sarepta Therapeutics (Nasdaq: SRPT) jumped nearly 15% Thursday after the US Food and Drug Administration (FDA) said it …

News
valeant_sign

US Congress Committee pressures Valeant to produce drug pricing documents

March 11, 2016
Medical Communications, Sales and Marketing Drug pricing, Michael Pearson, Valeant

Valeant’s tough month continued yesterday, with a US congressional committee pressuring the company to explain why it has not produced …

News
ivf_worldwide_teva_logos

Teva funds research to protect fertility in women diagnosed with cancer

March 11, 2016
Business Services, Research and Development Cancer, IVF Worldwide, Teva, fertility, radiotherapy

Israeli generics giant Teva has announced it will support IVF-Worldwide with a research grant to improve knowledge of fertility preservation …

News
vials_purple_liquid

Alphabet’s life science unit makes device to aid gathering of health data for research

March 11, 2016
Medical Communications, Research and Development Alphabet, Connectivity Bridge, Verily, google, life sciences

Verily, the life sciences unit of Alphabet, has unveiled Connectivity Bridge, a device designed to sync and collect medical information for …

News
sanofi_logo_on_building

Sanofi says its RA drug bested Humira in Phase III study

March 11, 2016
Medical Communications, Research and Development Humira, Regeneron, Sanofi

Sanofi and its R&D arm Regeneron Pharmaceuticals say their monoclonal antibody sarilumab outperformed AbbVie’s Humira in treating the symptoms of …

News
shutterstock_212432119

Vericel stock nearly doubles as heart failure drug meets primary endpoint in mid-stage trial

March 11, 2016
Medical Communications, Research and Development

Shares in US-based biotech firm Vericel nearly doubled on the Nasdaq on Thursday as the company reported its heart failure …

News
fougera

Novartis to unify Fougera’s US manufacturing plants

March 11, 2016
Manufacturing and Production, Medical Communications Fougera, Novartis, Sandoz, manufacturing

Novartis is planning to unify the two manufacturing plants used by Sandoz unit Fougera Pharmaceuticals in the US, expanding and …

News

FDA grants approval for first generic version of Viagra

March 10, 2016
Manufacturing and Production, Research and Development, Sales and Marketing FDA, Pfizer, Teva, erectile dysfunction, generic, viagra

The US Food and Drug Administration (FDA) has granted approval to the first generic version of Pfizer’s blockbuster erectile dysfunction …

News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

Two-drug combo shown to significantly shrink breast cancer in days

March 10, 2016
Medical Communications, Research and Development GSK, Herceptin, Novartis, Roche, Tyverb

Results of a clinical trial have revealed that Novartis’ Tyverb (lapatinib), in combination with Roche’s Herceptin (trastuzumab), can significantly shrink …

News
teva_copy

Teva issues US recall of amikacin sulfate injection due to glass identified in vials

March 10, 2016
Manufacturing and Production Teva, amikacin sulfate, glass, recall

Teva Pharmaceuticals has announced a voluntary recall of one lot of amikacin sulfate injection USP vials due to the potential …

News
msd_sanat_chattopadhyay_

New manufacturing boss for MSD

March 10, 2016
Manufacturing and Production, Medical Communications MSD, manufacturing

MSD has appointed Sanat Chattopadhyay president of the Merck Manufacturing Division (MMD) and an executive vice president of the company. …

Appointment
research_11

Researcher develops strategy to identify antimicrobial drugs that tackle drug-resistant pathogens

March 10, 2016
Manufacturing and Production, Research and Development anitmicrobial, drug discovery, drug repurposing, mohamed seleem, purdue university

A researcher from Purdue University’s College of Veterinary Medicine has developed a novel method of repurposing drugs to act as …

News
amarin_logo

Amarin wins case against FDA to promote Vascepa for off-label uses

March 10, 2016
Medical Communications, Research and Development, Sales and Marketing Amarin, FDA, first amendment, off label, vascepa

Amarin has announced a settlement with the US Food and Drug Administration (FDA) that resolves the dispute over the Irish-based …

News
lupin_pharma_logo

Lupin completes acquisition of US-based Gavis Pharmaceuticals

March 10, 2016
Research and Development, Sales and Marketing FDA, Gavis, Lupin, acquisition, generics

Indian drug manufacturer Lupin has announced the completion of its acquisition of New Jersey-based pharmaceutical firm, Gavis, in a deal …

News
patient_view

Survey reveals patient groups’ views on pharma industry

March 10, 2016
Research and Development, Sales and Marketing patientview

A new report, published by research and consultancy group PatientView, has revealed the attitude of more than 1,000 patient groups …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026